Publications by authors named "Peri Ravikumar"

Claim this Profile
T
The state of the art in secondary pharmacology and its impact on the safety of new medicines.
Richard J Brennan, Stephen Jenkinson, Andrew Brown, Annie Delaunois, Bérengère Dumotier, Ravikumar Peri

Nat Rev Drug Discov· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: The state of the art in secondary pharmacology and its impact on the safety of new medicines.
Richard J Brennan, Stephen Jenkinson, Andrew Brown, Annie Delaunois, Bérengère Dumotier, Ravikumar Peri

Nat Rev Drug Discov· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time for a Fully Integrated Nonclinical-Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective.
Hugo M Vargas, Michael G Rolf, Todd A Wisialowski, William Achanzar, Anthony Bahinski, Ravikumar Peri

Clin Pharmacol Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro secondary pharmacological profiling: An IQ-DruSafe industry survey on current practices.
Jean-Pierre Valentin, Jean-Michel Guillon, Stephen Jenkinson, Vivek Kadambi, Peri Ravikumar

J Pharmacol Toxicol Methods· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening technologies for ion channel drug discovery.
Georg C Terstappen, Renza Roncarati, John Dunlop, Ravikumar Peri

Future Med Chem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an improved IP(1) assay for the characterization of 5-HT(2C) receptor ligands.
Jean Y Zhang, Dianne M Kowal, Stanley P Nawoschik, John Dunlop, Mark H Pausch, Ravikumar Peri

Assay Drug Dev Technol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ion channel screening.
John Dunlop, Mark Bowlby, Ravikumar Peri, Gregory Tawa, James LaRocque

Comb Chem High Throughput Screen· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional screening of α7 nicotinic receptor ligands.
John Dunlop, Ravikumar Peri, Georg C Terstappen, Mark Bowlby

Expert Opin Drug Discov· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology.
John Dunlop, Mark Bowlby, Ravikumar Peri, Dmytro Vasilyev, Robert Arias

Nat Rev Drug Discov· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis